Possible clinical implications and future directions of managing bacterial biofilms in cutaneous leishmaniasis wounds.
Antibiotics
Biofilms
Cutaneous leishmaniasis
Debridement
Management
Microbiome
Journal
Tropical medicine and health
ISSN: 1348-8945
Titre abrégé: Trop Med Health
Pays: Japan
ID NLM: 101215093
Informations de publication
Date de publication:
26 Aug 2022
26 Aug 2022
Historique:
received:
20
06
2022
accepted:
19
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Cutaneous leishmaniasis (CL) lesions are chronic and result in disfiguring scars. The microbiological aspects of these wounds have not been systematically investigated. We have recently reported that 61.5% of CL wounds in a Sri Lankan cohort harboured bacterial biofilms, mainly composed of bacilli, Enterobacteriaceae, and Pseudomonas, which could delay wound healing. We have additionally reported that biofilms were significantly associated patients over 40 years of age, discharge, pain and/or itching of the wound, and high pus cell counts. Using this as background knowledge and other relevant literature, we highlight the importance of investigating the role of biofilms in CL wound healing, clinical indicators, cost-effective laboratory tests involving less invasive sampling techniques for diagnosing biofilms and potential therapeutic options for biofilm-containing CL wounds, such as adjunctive application of wound debridement and antimicrobial treatment along with anti-parasitic drugs.
Identifiants
pubmed: 36028889
doi: 10.1186/s41182-022-00455-y
pii: 10.1186/s41182-022-00455-y
pmc: PMC9414163
doi:
Types de publication
Journal Article
Langues
eng
Pagination
58Subventions
Organisme : University of Sri Jayewardenepura
ID : ASP/01/RE/MED/2019/40
Informations de copyright
© 2022. The Author(s).
Références
Adv Wound Care (New Rochelle). 2014 Jul 1;3(7):502-510
pubmed: 25032070
Ostomy Wound Manage. 2003 Nov;49(11):24-51
pubmed: 14652411
Indian J Plast Surg. 2012 May;45(2):193-202
pubmed: 23162216
Ann Surg. 2020 Jun;271(6):1174-1185
pubmed: 30614873
Clin Microbiol Infect. 2015 May;21 Suppl 1:S1-25
pubmed: 25596784
J Diabetes Res. 2014;2014:153586
pubmed: 24839608
Sci Rep. 2021 Nov 30;11(1):23181
pubmed: 34848752
Future Microbiol. 2012 Sep;7(9):1061-72
pubmed: 22953707
Diagnostics (Basel). 2021 Feb 11;11(2):
pubmed: 33670266
Front Microbiol. 2021 Nov 19;12:747834
pubmed: 34867864
Mem Inst Oswaldo Cruz. 2017 Sep;112(9):640-646
pubmed: 28902290
Adv Wound Care (New Rochelle). 2012 Jun;1(3):127-132
pubmed: 24527292
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638
Mem Inst Oswaldo Cruz. 2003 Dec;98(8):1093-5
pubmed: 15049096
Int J Womens Dermatol. 2019 Feb 10;5(3):158-165
pubmed: 31360749
Cell Host Microbe. 2017 Jul 12;22(1):13-24.e4
pubmed: 28669672
Indian J Dermatol. 2008;53(3):129-31
pubmed: 19882011
Appl Environ Microbiol. 2014 Apr;80(7):2176-85
pubmed: 24487536
NPJ Biofilms Microbiomes. 2020 May 1;6(1):21
pubmed: 32358500
Lett Appl Microbiol. 2021 Oct;73(4):477-485
pubmed: 34184296